A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer

Standard chemoradiotherapy with infusional 5FU for locally advanced pancreatic cancer (LAPC) has limited efficacy in this disease. The combination of Capecitabine (Cap) and Gemcitabine (Gem) are synergistic and are potent radiosensitisers. The aim of this phase I trial was thus to determine the high...

Descripción completa

Detalles Bibliográficos
Autores principales: Michael, M, Price, T, Ngan, S Y, Ganju, V, Strickland, A H, Muller, A, Khamly, K, Milner, A D, Dilulio, J, Matera, A, Zalcberg, J R, Leong, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634693/
https://www.ncbi.nlm.nih.gov/pubmed/19088724
http://dx.doi.org/10.1038/sj.bjc.6604827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634693/
https://www.ncbi.nlm.nih.gov/pubmed/19088724
http://dx.doi.org/10.1038/sj.bjc.6604827

Ejemplares similares